Sarah Cannon
June 01, 2023
SCRI to present latest oncology research insights at 2023 ASCO®...

More than 135 abstracts accepted for presentation across all phases of drug development

Read More
Sarah Cannon
May 15, 2023
Ishwaria Subbiah, MD joins SCRI as executive director for cancer care equity...

Dr. Ishwaria Subbiah to lead new programs focused on patient and clinical workplace experiences

Read More
Sarah Cannon
May 11, 2023
Vivek Subbiah, MD, joins SCRI to advance early-phase clinical research

Dr. Vivek Subbiah to serve as chief, early-phase drug development across SCRI's Research Network

Read More
Sarah Cannon
May 08, 2023
Mirati Therapeutics & SCRI announce strategic, community site focused partnership

SCRI and Mirati today announced a strategic partnership aimed at increasing diversity in clinical study recruitment practices.

Read More